Single award · contract
Oseltamivir Phosphate 75MG Capsules (Ndc: 47781-470-13); 10 Ct. Blisters Packs and Oseltamivir Phosphate 30MG…
Award ID: 75A50325F80013
FY2025 · complete year · data as of 2026-09-01
A single federal award, with both ends of the trail linked.
$227.7M
Total award value
Award 75A50325F80013 is a contract from the Department of Health and Human Services to Alvogen, Inc., $227.7M obligated, FY2025 to FY2027, for Oseltamivir Phosphate 75MG Capsules (Ndc: 47781-470-13); 10 Ct. Blisters Packs and Oseltamivir…. The work is performed in New Jersey. It is classified as NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals). Source
Agency ›
Department of Health and Human Services
Source
awarded→$227.7M
Recipient ›
Alvogen, Inc.
Source
performed in→
Description
Oseltamivir Phosphate 75MG Capsules (Ndc: 47781-470-13); 10 Ct. Blisters Packs and Oseltamivir Phosphate 30MG Capsules (Ndc: 47781-468-13); 10 Ct. Blisters Packs.
Award details
Award typeContract
PIID75A50325F80013
Action date2025
Period24 mo
Awarding agencyDepartment of Health and Human Services →
RecipientAlvogen, Inc. →
Place of performanceNew Jersey →
CategoryNAICS 325412PSC 6505
Competed?Not recordedSource
Total (exact)$227,679,090
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.